Insider sales of Krystal Biotech stock were disclosed to the SEC by executives.
2 reports, 2 independent
Updated Sep 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insider sales of Krystal Biotech stock were disclosed to the SEC by executives.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Krystal Biotech stock is seeing increased institutional investment activity, with related filings made on the SEC regarding its trading on the Nasdaq exchange.
- Insider Chris Freeman sold shares of Guardant Health during the reporting period, leading to an SEC filing on September 14, 2026.
- Micron Technology CEO Sanjay Mehrotra sold company stock via insider transaction and filed required disclosures with the SEC.
- A company involved in insider transactions and increased investment stakes disclosed filings to the SEC.
- SEC received filings regarding stock holdings from Williams Companies on September 22, 2026.